Gilead is accused of ‘downplaying or omitting altogether the clinical dangers experienced by patients from remdesivir use.’
⋮
Deborah Fust, the surviving spouse of Michael Fust, and Edward Pimentel, who says he was injured after receiving remdesivir, are accusing California-based Gilead of failing to mention documented side effects in its promotion of remdesivir.
⋮
The new suit comes after a court in Michigan ruled that remdesivir was not protected under federal law against an action brought by a man who needed his leg amputated after receiving remdesivir.
COMPLAINT FOR DAMAGES AND INJUNCTIVE RELIEF
1. Violations of the Consumers Legal Remedies Act Cal. Civ. Code §§ 1750 et seq.
2. Violations of the False Advertising Law Cal. Bus. & Prof. Code §§ 17500 et seq
3. Violations of the Unfair Competition Law Cal. Bus. & Prof. Code §§ 17200 et seq
4. Money Had and Received.
5. Negligent Misrepresentation.
6. Unjust Enrichment
My name is Jamie Scher, and I am one of the lawyers who filed the Class Action In Shasta County California against Gilead Sciences, Inc., maker of the lethal drug known as Remdesivir and/or Veklury. In case you don’t get through this entire Substack article, let me emphasize the most important point that I would like to make to everyone: DO NOT EVER TAKE THESE DRUGS, EVER!
There are links in the article cited above for participating in this case and for contributing to the costs.
A critically important fact about remdesivir is that this drug was studied for Ebola, and the results were so abysmal that the attempted “treatment” was cancelled; remdesivir had zero benefits, and greatly increased mortality just like the other “Safe and Effective” offerings. Dr. Fauci and his partners-in-crime knew about remdesivir’s safety profile, or lack thereof, and they absolutely knew that it would do nothing against PSYOP-19, but would result in renal failure which would then look a lot like C19 pneumonia, especially when combined with intubation; in other words, they always knew that they were murdering people.
All of these sociopaths must be rounded up, and given speedy trials.
They want you dead.
Do NOT comply.
— 2nd Smartest Guy in the World
Sources:
- Filed September 27, 2023. Fust vs. Gilead Sciences, Inc. Zach Stieber (Epoch Times). Superior Court of the State of California for the County of Shasta.
https://www.documentcloud.org/documents/23994749-class-action-complaint-against-gilead-over-remdesivir.
Cloud Document. - September 30, 2023. Zachary Stieber. “Class-Action Lawsuit Filed Against Remdesivir Manufacturer Over Alleged Deceptive Practices.” The Epoch Times.
https://www.theepochtimes.com/article/class-action-lawsuit-filed-against-remdesivir-manufacturer-over-alleged-deceptive-practices-5500317.
News. - October 1, 2023. 2nd Smartest Guy in the World. “Class-Action Lawsuit Filed Against Remdesivir Manufacturer Over Alleged Deceptive Practices.” 2nd Smartest Guy in the World.
https://www.2ndsmartestguyintheworld.com/p/class-action-lawsuit-filed-against.
Blog. - August 22, 2022. 2nd Smartest Guy in the World. “EXCLUSIVE LAWYER UPDATE: Class-Action Lawsuit Filed Against Remdesivir Manufacturer Over Alleged Deceptive Practices.” 2nd Smartest Guy in the World.
https://www.2ndsmartestguyintheworld.com/p/exclusive-lawyer-update-class-action.
Blog.
Related:
- December 12, 2019. Sabue Mulangu, Lori E. Dodd, Richard T. Davey, Olivier Tshiani Mbaya, Michael Proschan, Daniel Mukadi, Mariano Lusakibanza Manzo, Didier Nzolo, Antoine Tshomba Oloma, Augustin Ibanda, Rosine Ali, Sinaré Coulibaly, Adam C. Levine, Rebecca Grais, Janet Diaz, H. Clifford Lane, Jean-Jacques Muyembe-Tamfum, PALM Writing Group; Billy Sivahera, Modet Camara, Richard Kojan, Robert Walker, Bonnie Dighero-Kemp, Huyen Cao, Philippe Mukumbayi, Placide Mbala-Kingebeni, Steve Ahuka, Sarah Albert, Tyler Bonnett, Ian Crozier, Michael Duvenhage, Calvin Proffitt, Marc Teitelbaum, Thomas Moench, Jamila Aboulhab, Kevin Barrett, Kelly Cahill, Katherine Cone, Risa Eckes, Lisa Hensley, Betsey Herpin, Elizabeth Higgs, Julie Ledgerwood, Jerome Pierson, Mary Smolskis, Ydrissa Sow, John Tierney, Sumathi Sivapalasingam, Wendy Holman, Nikki Gettinger, David Vallée, Jacqueline Nordwall, and PALM Consortium Study Team. “A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.” The New England Journal of Medicine 381 (24): 2293–2303.
https://doi.org/10.1056/NEJMoa1910993.
Research Journal.
ZMapp and Remdesivir were eliminated from the study following an interim analysis during the trial for mortality reasons. Remdesivir was the most dangerous drug in that trial. This trial did not include a control. This trial was funded by NIAID. - June 11, 2020. Jonathan Grein, Norio Ohmagari, Daniel Shin, George Diaz, Erika Asperges, Antonella Castagna, Torsten Feldt, Gary Green, Margaret L. Green, François-Xavier Lescure, Emanuele Nicastri, Rentaro Oda, Kikuo Yo, Eugenia Quiros-Roldan, Alex Studemeister, John Redinski, Seema Ahmed, Jorge Bernett, Daniel Chelliah, Danny Chen, Shingo Chihara, Stuart H. Cohen, Jennifer Cunningham, Antonella D’Arminio Monforte, Saad Ismail, Hideaki Kato, Giuseppe Lapadula, Erwan L’Her, Toshitaka Maeno, Sumit Majumder, Marco Massari, Marta Mora-Rillo, Yoshikazu Mutoh, Duc Nguyen, Ewa Verweij, Alexander Zoufaly, Anu O. Osinusi, Adam DeZure, Yang Zhao, Lijie Zhong, Anand Chokkalingam, Emon Elboudwarej, Laura Telep, Leighann Timbs, Ilana Henne, Scott Sellers, Huyen Cao, Susanna K. Tan, Lucinda Winterbourne, Polly Desai, Robertino Mera, Anuj Gaggar, Robert P. Myers, Diana M. Brainard, Richard Childs, Timothy Flanigan. “Compassionate Use of Remdesivir for Patients with Severe Covid-19.” The New England Journal of Medicine 382 (24): 2327–36.
https://doi.org/10.1056/NEJMoa2007016.
Research Journal.
31% of patients had serious adverse events. (23% + 8%) The most common serious adverse events — multiple-organ-dysfunction syndrome, septic shock, acute kidney injury, and hypotension — were reported in patients who were receiving invasive ventilation at baseline. - September 2020. Marie Dubert, Benoit Visseaux, Valentina Isernia, Lila Bouadma, Laurène Deconinck, Juliette Patrier, Paul-Henri Wicky, Diane Le Pluart, Laura Kramer, Christophe Rioux, Quentin Le Hingrat, Nadhira Houhou-Fidouh, Yazdan Yazdanpanah, Jade Ghosn, Francois-Xavier Lescure. “Case Report Study of the First Five COVID-19 Patients Treated with Remdesivir in France.” International Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases 98 (September): 290–93.
https://doi.org/10.1016/j.ijid.2020.06.093.
Research Journal.
Four of the trial patients had to be removed from the trial early: two because they were heading toward liver failure, and two because they had such severe kidney failure they they required transplants. Two of the trial patients ultimately died. France decided that Remdesivir was too dangerous to use in their country. - April 2021. Alexandre O. Gérard, Audrey Laurain, Audrey Fresse, Nadège Parassol, Marine Muzzone, Fanny Rocher, Vincent L. M. Esnault, and Milou-Daniel Drici. “Remdesivir and Acute Renal Failure: A Potential Safety Signal From Disproportionality Analysis of the WHO Safety Database.” Clinical Pharmacology and Therapeutics 109 (4): 1021–24.
https://doi.org/10.1002/cpt.2145.
Research Journal.
See also, on this site: